Risk scores and coronary artery disease in patients with suspected acute coronary syndrome and intermediate cardiac troponin concentrations

Author:

Perez-Vicencio DanielORCID,Thurston Alexander JF,Doudesis DimitriosORCID,O’Brien Rachel,Ferry Amy V.ORCID,Fujisawa TakeshiORCID,Williams Michelle C.ORCID,Gray Alasdair J.ORCID,Mills Nicholas LORCID,Lee Kuan KenORCID

Abstract

AbstractBackgroundGuidelines recommend the use of risk scores to select patients for further investigation after myocardial infarction has been ruled out but their utility to identify those with coronary artery disease is uncertain.MethodsIn a prospective cohort study, patients with intermediate high-sensitivity cardiac troponin I concentrations (5 ng/L to sex-specific 99thpercentile) in whom myocardial infarction was ruled out were enrolled and underwent coronary computed tomography angiography (CCTA) after hospital discharge. HEART, EDACS, GRACE, TIMI, SCORE2 and PCE risk scores were calculated and the odds ratio (OR) and diagnostic performance for obstructive coronary artery disease determined using established thresholds.ResultsIn 167 patients enrolled (64±12 years, 28% female), 29.9% (50/167) had obstructive coronary artery disease. The odds of having obstructive disease was increased for all scores with the lowest and highest increase observed for an EDACS score ≥16 (OR 2.2 [1.1-4.6]) and a TIMI risk score ≥1 (OR 12.9 [3.0-56.0]), respectively. The positive predictive value (PPV) was low for all scores but was highest for a GRACE score >88 identifying 39% as high-risk for a PPV of 41.9% (30.4-54.2%). The negative predictive value (NPV) varied from 77.3% to 95.2% but was highest for a TIMI score of 0 identifying 26% as low-risk for a NPV of 95.2% (87.2-100%).ConclusionsIn patients with intermediate cardiac troponin concentrations in whom myocardial infarction has been ruled out, clinical risk scores can help identify patients with and without coronary artery disease, but the performance of established risk thresholds requires optimisation for this purpose.Clinical Trial Registrationhttps://clinicaltrials.gov/study/NCT04549805

Publisher

Cold Spring Harbor Laboratory

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3